Pre-biopsy MRIs can help doctors diagnose and treat prostate cancer more accurately. Here’s when you should get one.

Prostate cancer is one of the most common cancers in men but often goes unnoticed. Experts stress early screening, awareness ...

As a retired clinical laboratorian, retired hospital laboratory manager, and prostate-cancer survivor, I feel I must respond to the articles “Fewer Men Diagnosed With Prostate Cancer” and “Restricting ...

Lower urinary tract symptoms are not associated with an increased risk for high-grade prostate cancer, rendering biopsies and antigen testing unnecessary, a case-control study reports.

Comprehensive genetic testing using multigene testing panels for prostate cancer can arm genetic counselors with the information they need to guide precision therapy, even in men with early stage ...

CINCINNATI (WKRC) - Defense Secretary Lloyd Austin’s diagnosis of prostate cancer has specialists reminding everyone about the importance of early detection. But, many men are still not getting the ...

Cases of advanced prostate cancer have increased among American men ages 50 and older, while cases of early-stage disease have declined, a study published Wednesday found. The study looked at cases ...

Prostate-specific antigen screening was highest among African American men and those concerned about prostate cancer and lowest when physicians did not discuss the test. Objective: To examine factors ...

Some patients with prostate cancer may want to consider genetic testing as it could provide a guideline for treatment and information for secondary cancer risk, while also allowing families to better ...

Ads for ‘misleading’ prostate supplements and home testing kits banned - The Advertising Standards Authority said misleading claims could give false reassurance or make it harder to know when to speak ...

Ever felt like you're just waiting for the other shoe to drop, especially regarding medical test results? Francis Collins, the former NIH director, found himself in that situation, dancing the ...

Metastatic castration-resistant prostate cancer (CRPC) is the lethal form of the disease. Many groups have performed mutational or immunohistochemistry (IHC) testing in metastatic CRPC to identify ...